GlycoMar is a marine biotechnology company based near Oban, Scotland. We exploit natural products in marine invertebrate glycobiology to advance human health.

GlycoMar is an innovative drug discovery and development company pursuing untapped biological and chemical diversity to identify new drug candidates from marine organisms. GlycoMar is unique in its focus on the development of novel therapeutics from marine glycobiology. The company is targeting the identification of new anti-inflammatory drug candidates. This developing portfolio of lead compounds is being progressed towards early clinical trials.